WARPNINE is a patient-first Western Australian charity accelerating innovative clinical trials and translational research for pancreatic, upper gastrointestinal and rare cancers. For patients facing aggressive cancers, research cannot move quickly enough.
WARPNINE focuses on the critical gap where promising discoveries can stall—not because the science lacks potential, but because the funding, dedicated capacity or coordination needed to progress them is unavailable.
Through a lean and agile model, WARPNINE does more than provide funding. We work alongside clinicians, researchers, hospitals and industry to move high-potential ideas from the laboratory bench into clinical trials and, ultimately, closer to patient care.
Since 2021, the generosity of our supporters has helped advance pioneering trials, build dedicated research capacity and generate findings recognised internationally. By backing the right people and ideas at the moment support matters most, every WARPNINE partnership can help accelerate better treatments and create new possibilities for patients and their families.
